DOLORS COLOMER

Associate Professor

University of Barcelona

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dolors Colomer is an Associate Professor at the University of Barcelona, Spain. Her research focuses on the genomic alterations associated with various hematological malignancies, including chronic lymphocytic leukemia and acute myeloid leukemia. She has published extensively on diagnostic advancements and clinical outcomes in the field of myelofibrosis and monomorphic post–solid organ transplant lymphoproliferative disorders.

Articles (13)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (8)

Jan Zuna

Charles University

CZECH REPUBLIC

View details

Nicholas Cross

Professor of Human Genetics

University of Southampton

UNITED KINGDOM

View details

Alex Bataller Torralba

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Tobias Roider

University Hospital Heidelberg

GERMANY

View details

Monica Lopez-Guerra

Institut d'Investigacions Biomèdiques de Barcelona

SPAIN

View details

Daniela Zackova

Head physician, consultant

University Hospital Brno

CZECH REPUBLIC

View details

Aleix B. Fabregat Bolufer

Head of the Immunoassay Area

Hospital Clínic de Barcelona

SPAIN

View details

Adéla Benešová

Institute of Hematology and Transfusion Medicine

CZECH REPUBLIC

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

DOLORS COLOMER

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Whole Exome Sequencing of Intermediate-Risk Acute Myeloid Leukemia without Recurrent Genetic Abnormalities Offers Deeper Insights into New Diagnostic Classifications

Infrequent Presentations of Chronic NPM1-Mutated Myeloid Neoplasms: Clinicopathological Features of Eight Cases from a Single Institution and Review of the Literature

Association of Genomic Alterations with the Presence of Serum Monoclonal Proteins in Chronic Lymphocytic Leukemia

Decoding the molecular heterogeneity of pediatric monomorphic post–solid organ transplant lymphoproliferative disorders

Clinical Characteristics and Outcomes of Patients with Primary and Secondary Myelofibrosis According to the Genomic Classification Using Targeted Next-Generation Sequencing

Novel Tools for Diagnosis and Monitoring of AML

A unifying hypothesis for PNMZL and PTFL: morphological variants with a common molecular profile

Real-World Data on Chronic Myelomonocytic Leukemia: Clinical and Molecular Characteristics, Treatment, Emerging Drugs, and Patient Outcomes

Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy

EOMES is essential for antitumor activity of CD8<sup>+</sup> T cells in chronic lymphocytic leukemia.

Advantages and disadvantages of mouse models of chronic lymphocytic leukemia in drug discovery

Clinicobiological Characteristics and Outcomes of Patients with T-Cell Large Granular Lymphocytic Leukemia and Chronic Lymphoproliferative Disorder of Natural Killer Cells from a Single Institution

Challenges with Approved Targeted Therapies against Recurrent Mutations in CLL: A Place for New Actionable Targets

Collaborators (8)

Jan Zuna

Nicholas Cross

Alex Bataller Torralba

Tobias Roider

Monica Lopez-Guerra

Daniela Zackova

Aleix B. Fabregat Bolufer

Adéla Benešová

Make your next move.